Complete nucleotide sequence of the new simian T-lymphotropic virus, STLV-PH969 from a Hamadryas baboon, and unusual features of its long terminal repeat.

Por Van Brüssel, M, Goubau, P, Rousseau, R, Desmyter, J, Vandamme, A M
Publicado em 1997

A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas).

Por Goubau, P, Van Brussel, M, Vandamme, A M, Liu, H F, Desmyter, J
Publicado em 1994

Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir

Por Theys, K., Snoeck, J., Vercauteren, J., Abecasis, A. B., Vandamme, A.-M., Camacho, R. J.
Publicado em 2013

IFN-β induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-α in PBMCs of Adult T-cell Leukemia/Lymphoma patients

Por Dierckx, T, Khouri, R, Menezes, S M, Decanine, D, Farre, L, Bittencourt, A, Vandamme, A M, Van Weyenbergh, J
Publicado no Blood Cancer J (2017)

Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.

Por Witvrouw, M, Pauwels, R, Vandamme, A M, Schols, D, Reymen, D, Yamamoto, N, Desmyter, J, De Clercq, E
Publicado em 1992

Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline...

Por Pelemans, H, Esnouf, R, Dunkler, A, Parniak, M A, Vandamme, A M, Karlsson, A, De Clercq, E, Kleim, J P, Balzarini, J
Publicado em 1997

A36 Prevalence of HIV-1 subtypes in Slovenia with an emphasis on molecular and phylogenetic investigation of subtype A

Por Mlakar, J., Lunar, Maja M., Abecasis, A.B., Vandamme, A.-M., Tomažič, J., Vovko, T.D., Pečavar, B., Volčanšek, G., Poljak, M.
Publicado no Virus Evol (2017)

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxath...

Por Balzarini, J, Karlsson, A, Vandamme, A M, Pérez-Pérez, M J, Zhang, H, Vrang, L, Oberg, B, Bäckbro, K, Unge, T, San-Félix, A
Publicado em 1993

2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunode...

Por Balzarini, J, Pérez-Pérez, M J, San-Félix, A, Schols, D, Perno, C F, Vandamme, A M, Camarasa, M J, De Clercq, E
Publicado em 1992

A18 Random amplification with next-generation sequencing to cover HIV and HCV full-length genomes

Por Cuypers, L., Conceição-Neto, N., Dierickx, T., Schrooten, Y., Vrancken, B., Van Wijngaerden, E., Nevens, F., Vandamme, A.-M., Matthijnssens, J., Van Laethem, K.
Publicado no Virus Evol (2017)

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

Por Pauwels, R, Andries, K, Debyser, Z, Van Daele, P, Schols, D, Stoffels, P, De Vreese, K, Woestenborghs, R, Vandamme, A M, Janssen, C G
Publicado em 1993

SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.

Por Witvrouw, M, Balzarini, J, Pannecouque, C, Jhaumeer-Laulloo, S, Esté, J A, Schols, D, Cherepanov, P, Schmit, J C, Debyser, Z, Vandamme, A M, Desmyter, J, Ramadas, S R, de Clercq, E
Publicado em 1997

HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir

Por Theys, K., Vercauteren, J., Snoeck, J., Zazzi, M., Camacho, R. J., Torti, C., Schülter, E., Clotet, B., Sönnerborg, A., De Luca, A., Grossman, Z., Struck, D., Vandamme, A.-M., Abecasis, A. B.
Publicado em 2013

1,1,3-Trioxo-2H,4H-Thieno[3,4-e][1,2,4]Thiadiazine (TTD) Derivatives: a New Class of Nonnucleoside Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitors with...

Por Witvrouw, M., Arranz, M. E., Pannecouque, C., Declercq, R., Jonckheere, H., Schmit, J.-C., Vandamme, A.-M., Diaz, J. A., Ingate, S. T., Desmyter, J., Esnouf, R., Van Meervelt, L., Vega, S., Balzarini, J., De Clercq, E.
Publicado em 1998

A21 HIV-1 sub-subtype F1 outbreak among MSM in Belgium

Por Vinken, L., Fransen, K., Pineda-Peña, A.C., Alexiev, I., Balotta, C., Debaisieux, L., Devaux, C., García Ribas, S., Gomes, P., Incardona, F., Kaiser, R, Ruelle, J., Sayan, M., Paraschiv, S., Paredes, R., Peeters, M., Sonnerborg, A., Vancutsem, E., Van den Wijngaert, S., Van Ranst, M., Verhofstede, C., Vandamme, A.-M., Lemey, P., Van Laethem, K.
Publicado no Virus Evol (2017)